![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/evofem-biosciences-announces-financial-results-for-the-second-quarter-of-2024-302222084.html
https://www.moneycontrol.com/news/business/companies/lupin-divests-womens-health-specialty-business-in-us-to-evofem-for-84-million-12769646.html
https://www.prnewswire.com/news-releases/lupin-divests-us-commercial-womens-health-specialty-business-to-evofem-including-solosec-302196783.html
https://www.fiercepharma.com/pharma/troubled-evofem-marketer-contraceptive-gel-phexxi-sells-itself-aditxt-100m-deal
https://www.fiercepharma.com/marketing/fda-accuses-evofem-overstating-efficacy-contraceptive-gel
https://endpts.com/fda-watchdog-admonishes-evofem-for-marketing-brochure-for-its-contraceptive-phexxi/
https://www.prnewswire.com/news-releases/evofem-to-participate-in-the-virtual-investor-ask-the-ceo-conference-301956285.html
https://www.prnewswire.com/news-releases/evofem-biosciences-successfully-amends-spa-with-institutional-investor-301922632.html